Alcoholic Hepatitis
71
10
11
38
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
3 terminated out of 71 trials
92.7%
+6.1% vs benchmark
20%
14 trials in Phase 3/4
26%
10 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (71)
Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Chronic Hepatitis B Virus Infection in Zambia
Outcomes Using MARS for Patients With ALF
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
Intra-Hepatic Microbiota in Alcoholic Hepatitis
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment
Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
HA35 Moderate Alcoholic Hepatitis (AH) Study
A-TANGO Phase 2 Study
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis
Short Course Steroids in Alcohol Associated Hepatitis
IL-1 Signal Inhibition in Alcoholic Hepatitis
Alcoholic Hepatitis Network Observational Study
Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis